BALCX
Price
$34.71
Change
+$0.22 (+0.64%)
Updated
Jan 17 closing price
Net Assets
240.18B
VTARX
Price
$10.60
Change
+$0.02 (+0.19%)
Updated
Jan 17 closing price
Net Assets
640.87M
Ad is loading...

BALCX vs VTARX

Header iconBALCX vs VTARX Comparison
Open Charts BALCX vs VTARXBanner chart's image
American Funds American Balanced C
Price$34.71
Change+$0.22 (+0.64%)
VolumeN/A
Net Assets240.18B
Virtus Tactical Allocation R6
Price$10.60
Change+$0.02 (+0.19%)
VolumeN/A
Net Assets640.87M
BALCX vs VTARX Comparison Chart
Loading...
View a ticker or compare two or three
VS
BALCX vs. VTARX commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BALCX is a Buy and VTARX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
BALCX has more cash in the bank: 240B vs. VTARX (641M). VTARX pays higher dividends than BALCX: VTARX (1.70) vs BALCX (1.59). BALCX was incepted earlier than VTARX: BALCX (24 years) vs VTARX (4 years). BALCX is a more actively managed with annual turnover of: 171.00 vs. VTARX (23.00). BALCX has a lower initial minimum investment than VTARX: BALCX (250) vs VTARX (2500000). BALCX annual gain was more profitable for investors over the last year : 11.44 vs. VTARX (4.35).
BALCXVTARXBALCX / VTARX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence24 years4 years-
Gain YTD1.9380.952204%
Front LoadN/AN/A-
Min. Initial Investment25025000000%
Min. Initial Investment IRAN/AN/A-
Net Assets240B641M37,441%
Annual Yield % from dividends1.591.7094%
Returns for 1 year11.444.35263%
Returns for 3 years10.59-7.45-142%
Returns for 5 years25.92N/A-
Returns for 10 years49.96N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AVT53.560.71
+1.34%
Avnet
BKR46.540.21
+0.45%
Baker Hughes Company
VYGR5.070.01
+0.20%
Voyager Therapeutics
DEA11.520.02
+0.17%
Easterly Government Properties
SABS3.53-0.03
-0.84%
SAB Biotherapeutics